The Present and FutureCardiovascular Medicine and SocietyCerebral Venous Sinus Thrombosis in the U.S. Population, After Adenovirus-Based SARS-CoV-2 Vaccination, and After COVID-19
Cardiovascular Medicine and Society
Under an Elsevier user license
open archive
Key Words
cerebral
COVID-19
sinus
thrombosis
vaccine
Abbreviations and Acronyms
CDC
Centers for Disease Control and Prevention
COVID-19
coronavirus disease-2019
CVST
cerebral venous sinus thrombosis
J&J
Johnson & Johnson
MHRA
Medicines and Healthcare Products Regulatory Agency
SARS-CoV-2
severe acute respiratory syndrome-coronavirus-2
Cited by (0)
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center.
© 2021 by the American College of Cardiology Foundation. Published by Elsevier.